| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |